July 29, 2013 -- Researchers released data on Thursday that indicates Haemophilus influenzae type b is having a large impact in developing countries.
The research, carried out by 115 researchers in seven different countries over an eight year period, showed that the Hib vaccine is having a large impact on countries in Asia and Eastern Europe.
One example of the Hib vaccine’s effectiveness is in Mongolia, one of the earliest countries to introduce the vaccine. Cases of Hib meningitis decreased from 28 cases per 100,000 children in 2005 to two per 100,000 children in 2010. Other countries, including Gambia and Mozambique showed similar positive results.